| Company Name | Fiscal Year | EPS (Actual) | EPS (Estimated) | Revenue (Actual) | Revenue (Estimated) | Exchange | |||
|---|---|---|---|---|---|---|---|---|---|
| Loading past events... | |||||||||
|
Friday - Jan 10, 2025 |
|||||||||
|
Walgreens Boots Alliance
WBA
|
Q1 FY25 | $0.51 | $0.37 | $39.46B | $37.39B |
NASDAQ |
|||
| Q4 FY24 | $3.09 | $3.07 | $15.84B | $15.22B |
NYSE |
||||
| Q4 FY24 | $1.85 | $1.74 | $15.56B | $14.19B |
NYSE |
||||
|
Constellation Brands
STZ
|
Q3 FY25 | $3.25 | $3.31 | $2.46B | $2.53B |
NYSE |
|||
|
Neogen
NEOG
|
Q3 FY25 | $0.11 | $0.09 | $231.26M | $228.07M |
NASDAQ |
|||
|
E2open Parent Holdings
ETWO
|
Q3 FY25 | $0.05 | $0.05 | $151.66M | $153.01M |
NYSE |
|||
|
WD-40
WDFC
|
Q1 FY25 | $1.39 | $1.29 | $153.50M | $149M |
NASDAQ |
|||
|
Accolade
ACCD
|
- | -$0.30 | -$0.32 | $105.06M | $142.73M |
NASDAQ |
|||
|
Hurco Companies
HURC
|
- | -$0.23 | - | $53.70M | - |
NASDAQ |
|||
|
Anixa Biosciences
ANIX
|
- | -$0.09 | -$0.11 | - | - |
NASDAQ |
|||
